Chapter 89
Acute Deep Vein Thrombosis
Anthony J. Comerota,
Anthony J. Comerota
Search for more papers by this authorAnthony J. Comerota,
Anthony J. Comerota
Search for more papers by this authorBook Editor(s):Enrico Ascher,
L. H. Hollier,
D. Eugene Strandness,
Jonathan B. Towne,
Keith Calligaro,
K. Craig Kent,
Gregory L. Moneta,
William H. Pearce,
John J. Ricotta,
Henry Haimovici,
Enrico Ascher
Search for more papers by this authorL. H. Hollier
Search for more papers by this authorD. Eugene Strandness
Search for more papers by this authorJonathan B. Towne
Search for more papers by this authorKeith Calligaro
Search for more papers by this authorK. Craig Kent
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorWilliam H. Pearce
Search for more papers by this authorJohn J. Ricotta
Search for more papers by this authorHenry Haimovici
Search for more papers by this authorFirst published: 01 January 2004
Summary
This chapter contains section titled:
-
Diagnosis
-
Management of Acute Deep Venous Thrombosis
-
Treatment Strategies
-
Upper Extremity Deep Vein Thrombosis
References
- Silverstein MD, Heit JA, et al. Trends in the in incidence of deep vein thrombosis and pulmonary embolism: A 25-year-old population-based study. Arch Intern Med 1998; 158: 585–593.
- Almen T, Nylander G. Serial phlebography of the normal lower leg during muscular contraction and relaxation. Acta Radiol 1961; 57: 264.
- Clark C, Cotton LT. Blood flow in deep veins of the legs: recording technique and evaluation of methods to increase flow during operation. Br J Surg 1968; 55: 211.
- Nicolaides AN, Kakkar VV, Renney JTG. The soleal sinuses and stasis. Br J Surg 1971; 58: 307.
- Gibbs NM. Venous thrombosis of the lower limb with particular reference to Bedrest. Br J Med 1957; 45: 209.
- Stead RB. The hypercoagulable state. In SZ Goldhaber, ed. Pulmonary Embolism and Deep Venous Thrombosis. Philadelphia: WB Saunders, 1985; 161.
- Hirsh J, Barlow GH, et al. Diagnosis of prethrombotic state in surgical patients. Contemp Surg 1980; 16: 65.
- Schaub RG, Lynch PR, Steward GJ. The response of canine veins to three types of abdominal surgery: a scanning and transmission electron microscope study. Surgery 1978; 83: 411.
- Stewart GJ, Alburger PD, et al. Total hip replacement induces injury to remote veins in a canine model. J Bone Joint Surg 1983; 65: 97.
- Comerota AJ, Stewart GJ, et al. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 1989; 106: 301.
- Stewart GJ, Lachman JW, et al. Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or total knee replacement. Ultrasound Med Biol 1990; 16: 133.
- Kakkar VV, Stamatakis JD, et al. Prophylaxis for postoperative deep vein thrombosis: synergistic effect of heparin and dihydroergotamine. J Am Med Assoc 1979; 241: 39.
- The Multicenter Trial Committee: Dihydroergotamine/heparin prophylaxis of postoperative deep vein thrombosis. J Am Med Assoc 1984; 251: 2960.
-
Biesaw NE,
Comerota AJ, et al.
Dihydroergotaine/heparin in the prevention of deep vein thrombosis after total hip replacement.
J Bone Joint Surg
1988;
70-A:
2.
10.2106/00004623-198870010-00002 Google Scholar
-
Virchow R.
Neuer Fall von todlicher Emboli der Lungenarterie.
Arch Pathol Anat
1856;
10:
225.
10.1007/BF01933614 Google Scholar
- Anderson FA Jr, Wheeler HB, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worchester DVT Study. Arch Intern Med 1991; 151: 933.
-
Dalen JE,
Alpert JS.
Natural history of pulmonary embolism.
Prog Cardiovasc Dis
1975;
17:
257.
10.1016/S0033-0620(75)80017-X Google Scholar
- Hirsh J, Hull RD. Pathogenesis of venous thromboembolism and clinical risk factors. In: H Hirsh, RD Hull, eds. Venous Thromboembolism: Natural History, Diagnosis and Management. Boca Raton, FL: CRC Press, 1987;5.
- Johnson BF, Manzo RA, et al. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one-to-six year followup. J Vasc Surg 1995; 21: 307–313.
- Shull KC, Nicolaides AN, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg 1979; 114: 1304–1308.
- Hull RD, Raskob GE, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986; 315: 1109–1113.
- Ginsberg JS, Keaton C, et al. The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. Arch Intern Med 1997; 157: 1077.
- Scarano L, Bernardi E, et al. Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. Thromb Res 1997; 86: 93.
- Carpenter JP, Holland GA, et al. Magnetic reasonance venography for detection of deep venous thrombus: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg 1993; 18: 734.
-
Cranley JJ,
Canos AJ,
Sull WJ.
The diagnosis of deep venous thrombosis: fallibility of clinical symptoms and signs.
Arch Surg
1976;
III:
34.
10.1001/archsurg.1976.01360190036005 Google Scholar
- Wells PS, Hirsh J, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326–1330.
- The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). J Am Med Assoc 1990; 268: 2753.
- Bergqvist D. Efficacy and safety of enoxaparin versus unfractionated heparin for randomized multicentre trial with venographic assessment. Br J Surg 1997; 84: 1099.
- Comerota AJ, White JV, Katz ML. Diagnostic methods for deep vein thrombosis: venous Doppler examination, phleborheography, iodine-125 fibrinogen uptake and phlebography. Am J Surg 1985; 150: 14.
- Hull RD, Hirsh H, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep vein thrombosis: a randomized trial. Ann Intern Med 1985; 102: 21.
- Comerota AJ, Cranley JJ, et al. Phleborheography: results of a ten-year experience. Surgery 1982; 91: 573.
- Cranley JJ, Canos AJ, et al. Phleborheographic technique for diagnosis of deep vein thrombosis of the lower extremities. Surg Gynecol Obstet 1975; 141: 331.
- Comerota AJ, Katz ML, et al. The comparative value of noninvasive testing for diagnosis and surveillance of deep venous thrombosis. J Vasc Surg 1988; 7: 40.
- Comerota AJ, Katz ML, et al. Venous duplex imaging: Should it replace hemodynamic tests for deep venous thrombosis? Vasc Surg 1990; 11: 53.
- Ginsberg JS, Caco CC, et al. Venous thrombosis in patients who have undergone major hip or knee surgery: detection with compression US and impedance plethysmography. Radiology 1991; 181: 651.
- Heijboer H, Buller HR, et al. A comparison of realtime compression ultrasonography with impedance plethysmography for the diagnosis of deep vein thrombosis in symptomatic outpatients. N Engl J Med 1993; 329: 1365.
- Bauer JJ. Surgical management of primary and recurrent varicose veins. In: JST Gloviczki, ed. Handbook of Venous Disorders: Guidelines of the American Venous Forum. Vol. 1. London: Chapman & Hall, 1996; 394–415.
- Boneu B, Bes G, et al. D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1 + 2: diagnosis value of clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28.
- Rowbotham BJ, Carrol P, et al. Measurement of cross-linked fibrin derivatives: use in the diagnosis of venous thrombosis. Throm Haemost 1987; 57: 59.
- Bounameaux H, De Moerloose P, et al. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 71: 1.
- Gitel SN, Wessler S. The antithrombotic effects of warfarin and heparin following infusion of tissue thromboplastin in rabbits: clinical implication. J Lab Clin Med 1979; 94: 481–488.
- Wessler S, Reimer L, et al. Serum-induced thrombosis: studies of its induction and evolution under controlled conditions in vivo. Circulation 1959; 20: 264–274.
- Chui HM, Hirsh J, et al. Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. Blood 1977; 49: 171–184.
- Morris TA, Marsh JJ, et al. Antibodies against the fibrin B-chain amino terminus detect active canine venous thrombi. Circulation 1997; 96: 3173–3179.
- Poller L, Tomson JM, Yee KF. Heparin and partial thom-boplastin time: an international survey. Br J Haematol 1980; 44: 161–165.
- Triplett DA, Harris CS, Koepke JA. The effect of heparin on the activated partial thromboplastin time. Am J Clin Pathol 1978; 70: 556–559.
- Hull RD, Raskob GE, et al. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 1997; 157: 2562–2568.
- Wester JP, de Valk HW, et al. Risk factors for bleeding during treatment of acute venous thromboembolism. Thromb Haemost 1996; 76: 682–688.
- Anand S, Ginsberg JS, et al. The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. Arch Intern Med 1996; 156: 1677–1681.
- Anand SS, Bates S, et al. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med 1999; 159: 2029–2032.
- de Swart CAM, Nijmeyer B, et al. Kinetics of intravenously administered heparin in normal humans. Blood 1982; 60; 1251.
- Olsson P, Lagergren H, Ek, S. The elimination from plasma of intravenous heparin: an experimental study on dogs and humans. Acta Med Scand 1963; 173: 619.
- Glimelius B, Busch C, Hook M. Binding of heparin on the surface of cultured human endothelial cells. Throm Res 1978; 12: 773.
- Rosenberg RD. The heparin-antithrombin system: a natural anticoagulation mechanism. In: RW Colman, J Hirsh, VJ Marder, EW Salzman, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 2nd edn. Philadelphia: JB Lippincott, 1987; 1373–1392.
- Hull RD, Raskob GE, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986; 315: 1109.
- Brandjes DPM, Buller HR, et al. Comparative trial of heparin and oral anticoagulants in the initial treatment of proximal deep vein thrombosis. N Engl J Med 1992; 327: 1485.
- Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep vein thrombosis. Arch Intern Med 1988; 148: 1321–1325.
- Hull RD, Raskob GE, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152: 1589–1595.
- Raschke RA, Reilly BM, et al. The weight-based heparin dosing nomogram compared with a 'standard care' nomogram: a randomized controlled trial. Ann Intern Med 1993; 119: 874–881.
- Greinacher A. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Throm Hemost 1995; 21: 106–116.
- Warkentin TE, Levine MN, et al. Heparin-induced thrombocytopenia in patients treated with low- molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330–1335.
- Bara L, Billaud E, et al. Comparative pharmocokinetics of low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Throm Res 1985; 39; 631–636.
- Lensing AWA, Prins MN, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta analysis. Arch Intern Med 1995; 155, 601–607.
- Lohr JM, James KV, et al. Calf vein thrombi are not a benign finding. Am J Surg 1995; 170: 86–90.
- Philbrick JT, Becker DM. Calf vein thrombosis: a wolf in sheep's clothing? Arch Intern Med 1988; 148: 2131–2138.
- Monreal M, Barroso RJ, et al. Asymptomatic pulmonary embolism in patients with deep vein thrombosis: Is it useful to take a lung scan to rule out this condition? J Cardiovasc Surg 1989; 30: 104–107.
- Masuda EM, Kistner RL, Ferris EB 3rd. Long-term effects of superficial femoral vein ligation: thirteen-year followup. J Vasc Surg 1992; 16: 741–749.
- Conti S, Daschbach J, Blaisdell FW. A comparison of high dose versus conventional dose heparin therapy for deep vein thrombosis. Surgery 1982; 92: 972–976.
- Tollefsen DM, Majerus DW, Blank MK. Heparin Cofactor II: purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J. Biol Chem 1982; 247: 2162–2169.
- Kearon C, Gent M, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 342: 955–960.
- Hyers TM, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 1002; 119: 1765–1935.
- Calligaro KD, Bergen WS, et al. Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement. Ann Vasc Surg 1991; 5 (2): 186.
- Cohen JR, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery 1991; 109 (1): 12.
- Whitney BA, Kerstein MD. Thrombocytopenia and cancer. Use of the Kim-Ray Greenfield filter to prevent thromboembolism. South Med J 1987; 80: 1246.
- Masuda EM, Kistner RL, Ferris EB. Long-term effects of superficial femoral vein ligation: thirteen-year followup. J Vasc Surg 1992; 16: 741.
- Greenfield LJ, Rutherford RB. Recommended reporting standards for vena caval filter placement and patient followup: Vena Caval Filter Consensus Conference. J V a sc Interv Radiol 1999; 10: 1013–1019.
- Jones, JA BT. The Greenfield filter as the primary means of therapy in venous thrombembolic disease. Surg Gynecol Obstet 1991; 172: 253–292.
- Leach TA, Pastena JA, et al. Surgical prophylaxis for pulmonary embolism. Am Surg 1994; 60: 292–295.
- O'Donnell TF, Browne NL, et al. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977; 22: 483.
- Akesson H, Brudin L, et al. Venous function assessed during a 5-year period after iliofemoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990: 4: 43–48.
- Plate G, Einarsson E, et al. Thrombectomy with temporary arteriovenous fistula in acute iliofemoral venous thrombosis. J Vasc Surg 1984; 1: 867.
- Plate G, Akesson H, et al. Long-term results in venous thrombectomy combined with a temporary arteriovenous fistula. Eur J Vas Surg 1990: 4: 483–489.
- Comerota AJ, Aldridge SC, et al. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994; 20: 244–254.
- Warkentin TE, Chong BH, Greinacher A. Heparin-in-duced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1–7.
- Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502–507.
- Wallis DE, Quintos R, et al. Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia. Chest 1999; 116: 1333–1338.
- Warkentin TE, Elevathil LJ, et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997; 127: 804–812.
-
Warkentin TE,
Sikov WM,
Lillicrap DP.
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia.
Am J Hematol
1999;
62:
44–48.
10.1002/(SICI)1096-8652(199909)62:1<44::AID-AJH7>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- Warkentin TE. Heparin-induced thrombocytomapenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Tranfus Med Rev 1996; 10: 249–258.
- Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993; 70: 546–61.
- Warkentin TE. Danaparoid (Orgaran) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation and evaluation of the clinical significance of in vitro cross-reactivity (XR) of Danaparoid for HIT-IgG. Blood 1996; 88 (Suppl. 1): 626a.
- Lewis BE, Wallis DE, Matthai W, for the ARG-911 Study Investigators. Argatroban provides effective and safe anticoagulation in patients with heparin-induced thrombocytopenia: a prospective, historical controlled study. J Am Coll Cardiol 2000: 35 (Suppl.A): 266A (Abstract 832–2).
- Warkentin TE, Chong BH, Greinacher A. Heparin-in-duced thrombocytopenia: towards consensus. Throm Haemost 1998; 79: 1–7.
- Greinacher A, Volpel H, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999; 99: 73–80.
